Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 693 of 6351
-
Vutrisiran shows promise for Long-Term control of rare heart condition
Disease control By invitation onlyThe purpose of this study is to obtain safety, efficacy, and pharmacodynamic data on the use of vutrisiran in patients with ATTR amyloidosis with cardiomyopathy who continued on extended use of vutrisiran, or switched from patisiran.
Phase 3 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug could save transplanted kidneys from rejection
Disease control OngoingIn this study, researchers will learn more about the use of felzartamab in kidney transplant patients who have antibody-mediated rejection, also known as AMR. Kidney transplants can save lives for people with kidney failure. But even after a successful transplant, the body's immu…
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can smarter screening save premature Babies' sight?
Knowledge-focused CompletedThe purpose of the study is to explore the current incidence rate of retinopathy of prematurity (ROP) in China and to explore more appropriate screening criteria for ROP.
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Can a new injection help tackle obesity?
Disease control CompletedThis study is testing a new study medicine to treat people living with overweight or obesity. The aim of this study is to see if the medicine is safe, how it works in human body, and what human body does to the study medicine. Participants will either get the new study medicine N…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a glowing mouthwash spot oral cancer before biopsy?
Diagnosis Recruiting nowGiven the morphological and clinical similarities between certain oral malignant neoplasms and benign conditions such as oral ulcerations or inflammatory lesions, the potential for misdiagnosis is significant. Currently, histopathological examination via tissue biopsy remains the…
Sponsor: Yunnan Cancer Hospital • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
New hope for liver cancer patients with cirrhosis: immunotherapy combo under study
Disease control Recruiting nowThis is a single-arm, phase II study of patients with advanced liver cancer or hepatocellular carcinoma (HCC) who are eligible for first-line treatment with T300+D. The invesitgators hypothesize that T300+D will be safe and tolerated in CP-B patients with HCC. HCC mostly affects …
Phase 2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
A needle, not a scalpel: new device aims to create dialysis access in minutes
Disease control OngoingThe goal of this clinical trial is to evaluate, in a clinical setting, the feasibility of vein enlargement at the site of the arteriovenous fistula created percutaneously, using the DisTal device ("DisTal AVF"). The main question the study aims to answer is what is the rate of su…
Sponsor: Distal Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can we predict lung damage from CAR t-cell therapy?
Knowledge-focused CompletedBackground and Rationale Chimeric Antigen Receptor (CAR) T-cell therapies are emerging as a revolutionary treatment for hematological malignancies. However, this treatment carries a non-negligible clinical risk of pulmonary complications, which present as varied syndromes. These …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
New antiviral pill aims to keep High-Risk COVID patients out of hospital
Disease control Recruiting nowResearchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. However, people with certain health conditions or other factors have a high risk (chance) of getting severely ill from COVID-…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Blood test could spare thousands from unneeded colonoscopies
Diagnosis Recruiting nowThe project aims to investigate whether colorectal cancer screening can be improved using blood tests, thereby reducing the number of unnecessary colonoscopies. The Danish colorectal cancer screening program was implemented in 2014, and currently, all individuals aged 50-74 are i…
Sponsor: Vejle Hospital • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Could a peptide supercharge COVID-19 vaccines for seniors?
Vaccine Recruiting nowThe goal of this research is to learn more about ZADAXIN® (trade name; thymalfasin generic; Ta1 for short) and determine if Ta1 has any benefit in increasing the immune response to the COVID-19 vaccine. Ta1 has been shown to stimulate the immune system to fight infections. This …
Phase 1 • Sponsor: The Methodist Hospital Research Institute • Aim: Vaccine
Last updated Jul 18, 2026 00:00 UTC
-
Engineered cord blood cells take aim at stubborn colorectal cancer
Disease control OngoingTo find the highest and/or recommended dose of TROP2-CAR-NK cells combined with cetuximab in participants with MRD CRC.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New combo therapy targets Hard-to-Treat lymphoma
Disease control Recruiting nowThis phase II trial studies the side effects of acalabrutinib, obinutuzumab, and glofitamab and how well they work together for treating patients with mantle cell lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment …
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a steroid injection double as a painkiller for brain surgery?
Symptom relief CompletedThis study aimed to test the hypothesis that pre-emptive scalp infiltration with a steroid (dexamethasone) plus a local anesthetic (xylocaine) could achieve superior postoperative analgesic effects to a local anesthetic (xylocaine) plus epinephrine in adult patients undergoing a …
Sponsor: Assiut University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Cord blood cells take on lymphoma: new hope for relapsed patients
Disease control Recruiting nowTo study the safety and effectiveness of cord blood-derived IL-10/IL-15 CD19-CAR NK in patients with B-cell non-Hodgkin's lymphoma
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Brazilian diabetes prevention program aims to stop type 2 diabetes before it starts
Prevention Recruiting nowThe aim of this multicenter, randomized controlled trial is to assess the effectiveness of the Brazilian Diabetes Prevention Program (delivered face-to-face or via e-health) in preventing type 2 diabetes (T2D) in at least 1,305 adults at high risk of T2D over a 3-year follow-up p…
Sponsor: Beneficência Portuguesa de São Paulo • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Can a new drug outperform standard care for chemotherapy nerve pain?
Symptom relief CompletedTo conduct a two-arm, parallel, prospective, randomized controlled, open-label trial to compare the efficacy of the novel drug mirogabalin with the conventional treatment duloxetine in reducing pain associated with chemotherapy-induced peripheral neuropathy (CIPN). There will be…
Sponsor: Pusan National University Yangsan Hospital • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Can At-Home malaria pills work as well as supervised care?
Disease control CompletedThe study was designed to evaluate the current efficacy of this combination therapy against P. vivax, given the possibility of misuse or inadequate adherence to the regimen due to its lengthy treatment duration, in one of a vivax-endemic area in southwest Ethiopia. A 42-day in vi…
Sponsor: Jimma University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New daily pill could stop painful swelling attacks for HAE patients
Disease control OngoingThis is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of once-daily orally administered deucrictibant extended-release tablet compared to placebo for prophylaxis to prevent angioedema attacks in participants aged ≥ …
Phase 3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Magic mushroom compound shows promise for depression in new trial
Symptom relief CompletedThis randomized controlled clinical trial evaluates the effectiveness of psilocybin and psilocybin-assisted cognitive behavioral therapy (CBT) in the management of Major Depressive Disorder (MDD). The study aims to compare the effects of psilocybin-only therapy, CBT, and psilocyb…
Phase 2 • Sponsor: Khyber Medical University Peshawar • Aim: Symptom relief
Last updated Jun 26, 2026 12:50 UTC